Apollo Hospitals Enterprise Ltd is set to revolutionize cancer treatment in India with the establishment of a Comprehensive Oncology Centre featuring the country’s first Proteus One Proton System. This ambitious project, requiring an investment of Rs 250 crores, is planned over the next three years and will include state-of-the-art ancillary equipment. The hospital has partnered with Ion Beam Applications (IBA) to bring this cutting-edge technology to India.
Key Highlights of the Upcoming Proteus One Proton Beam Therapy Centre
-
Project Scope: Establishment of a Comprehensive Oncology Centre equipped with the Proteus One, a single gantry Proton Beam Therapy system.
-
Current Chennai Proton Centre Capacity: Designed to treat 850 patients per annum, currently catering to 500+ patients per annum.
-
Planned Proton Centre Expansion: The new facility will enable treatment for an additional 350 patients per annum.
-
Timeline: The Hyderabad-based centre is expected to be operational by FY 2028.
-
Investment: Rs 250 crores.
-
Funding Source: Internal Accruals.
-
Objective: To expand Comprehensive Oncology Care and enhance cancer treatment accessibility.
Advancing Proton Therapy in India
Apollo Hospitals pioneered Proton Therapy in India in 2019 with the launch of the Apollo Proton Cancer Centre (APCC) in Chennai—the first and only Proton Therapy facility in South Asia and the Middle East. Since its inception, the centre has treated over 2,000 patients from 147 countries. Proton therapy is particularly effective in treating tumors of the central nervous system, head and neck, pediatric and urological cancers, and complex malignancies.
The Proteus One system will feature the latest DynamicARC® beam delivery technology, offering superior precision and efficiency in targeting tumors, subject to statutory approvals.
Strengthening India’s Position in Oncology Innovation
With this initiative, Apollo Hospitals reaffirms its commitment to ensuring India remains at the forefront of medical advancements, giving patients access to world-class treatment options. By integrating Proteus One Proton Therapy, Apollo aims to:
-
Enhance clinical outcomes and improve the quality of life for cancer patients.
-
Foster knowledge sharing and training opportunities for oncologists.
-
Encourage the adoption of advanced treatment modalities across India and beyond.
